Fujifilm evaluates Avigan to treat Covid-19 in US

13 April 2020 (Last Updated April 13th, 2020 10:59)

Japanese company Fujifilm has launched a Phase II clinical trial of its influenza drug Avigan (favipiravir) to treat Covid-19 patients in the US.

Around 50 coronavirus patients will be enrolled at Brigham and Women’s Hospital, Massachusetts General Hospital and the University of Massachusetts Medical School.

Read the full article here